SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-028040
Filing Date
2017-05-16
Accepted
2017-05-16 20:06:57
Documents
1
Period of Report
2017-05-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v467232_3.html 3  
1 OWNERSHIP DOCUMENT v467232_3.xml 3 9545
  Complete submission text file 0001144204-17-028040.txt   12190
Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 6177782500
RA Capital Healthcare Fund LP (Reporting) CIK: 0001315082 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38096 | Film No.: 17850071

Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Reporting) CIK: 0001346824 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38096 | Film No.: 17850073

Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address
Kolchinsky Peter (Reporting) CIK: 0001384859 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38096 | Film No.: 17850072

Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Issuer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations